Journal Guide

Infectious Diseases and Therapy is an open access, internationally peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3-4 weeks from acceptance). Emphasis is placed on high quality pre-clinical, clinical (phases 1-4), and real world research around the discovery,  development, and use of infectious disease therapies. The journal also encourages diagnostic,  pharmacoeconomic, public health, educational, and quality of life studies as well as research around the prevention and management of infectious disease. Areas of focus include, but are not limited to, chronic infections, vaccines, drug-resistant pathogens, microbiology, epidemiology, and tropical, emergent, and sexually-transmitted diseases.The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research papers, drug reviews, case reports, and short communications. Each paper is accompanied by a bulleted slide summary to give a time-efficient overview of the content. All submissions have the option to include slide sets, video components, animations, and/or interactive case studies.Infectious Diseases and Therapy publishes supplements and special issues (in English or a local language). Material appropriate for supplements/special issues include: sponsored meeting proceedings, roundtable discussions, workshop reports, case series, and collections of articles on the same topic. All articles are subject to peer review, and must adhere to the IJCME and GPP policies on acknowledgments/disclosures. Proposals for supplements are welcomed, and should be addressed to clare.shepherd@springer.comFor authors: Upon acceptance of your article for publication, you will be required to pay the article open access fee of £175/€200/$260 per printed page. This will enable you to keep the copyright: you are simply assigning the exclusive right to any commercial use of the article to Springer., Your article will be immediately and permanently available with open access.

Medical professionals seeking an infectious diseases journal with true clinical value need look no further than Infectious Diseases in Clinical Practice. Here, clinicians can get full coverage consolidated into one resource, with pertinent new developments presented in a way that makes them easy to apply to patient care. Backed by the expertise and commitment of distinguished clinician-editors, the journal delivers the vital information needed to optimally prevent and treat infectious diseases.Website: www.infectdis.comIndividual and In-Training subscribers receive fully searchable online access to articles from Volume 1 to the present8212;now available on a powerful new website! This best-in-class website platform uses Web 2.0 functionality to provide an enhanced online experience through such features as: saved searches, personal article collections, easy image downloads to PowerPoint, and more.

Infectious Diseases in Obstetrics and Gynecology is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies related to the management of infectious diseases in obstetrics and gynecology.

Infectious Diseases of Poverty is an open access, peer-reviewed journal publishing topic areas and methods that address essential public health questions relating to infectious diseases of poverty. These include various aspects of the biology of pathogens and vectors, diagnosis and detection, treatment and case management, epidemiology and modeling, zoonotic hosts and animal reservoirs, control strategies and implementation, new technologies and application. Transdisciplinary or multisectoral effects on health systems, ecohealth, environmental management, and innovative technology are also considered.

Infectious Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews and research articles written by leaders in the field covering a range of current topics on drug targets involved in infectious disorders. As the discovery, identification, characterization and validation of novel human drug targets for anti-infective drug discovery continue to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug design, discovery and development.

In the past few years the fields of infinite dimensional analysis and quantum probability have undergone increasingly significant developments and have found many new applications, in particular, to classical probability and to different branches of physics. The number of first-class papers in these fields has grown at the same rate. This is currently the only journal which is devoted to these fields.It constitutes an essential and central point of reference for the large number of mathematicians, mathematical physicists and other scientists who have been drawn into these areas. Both fields have strong interdisciplinary nature, with deep connection to, for example, classical probability, stochastic analysis, mathematical physics, operator algebras, irreversibility, ergodic theory and dynamical systems, quantum groups, classical and quantum stochastic geometry, quantum chaos, Dirichlet forms, harmonic analysis, quantum measurement, quantum computer, etc. The journal reflects this interdisciplinarity and welcomes high quality papers in all such related fields, particularly those which reveal connections with the main fields of this journal.The principal objective of this journal is to provide an up-to-date overview of the state-of-the-art in its fields of competence.Special issues devoted to single topic of particular current interest will also be published in this journal.

Inflammation presents the latest international advances in experimental and clinical research on the physiology, biochemistry, cell biology, and pharmacology of inflammation. Published items include full-length scientific reports, short definitive articles, and papers from meetings and symposia proceedings. The journal's coverage extends to acute and chronic inflammation; mediators of inflammation; mechanisms of tissue injury and cytotoxicity; pharmacology of inflammation; and clinical studies of inflammation and its modification.

Inflammation Research (IR) publishes peer-reviewed papers on all aspects of inflammation and related fields including histopathology, immunological mechanisms, gene expression, mediators, experimental models, clinical investigations and the effect of drugs. Related fields are broadly defined and include for instance, allergy and asthma, shock, pain, joint damage, skin disease as well as clinical trials of relevant drugs.
Bibliographic Data
First published in 1969
Renamed in 1995
1 volume per year, 12 issues per volume
+ 2 supplements, in free sequence
Format: 21 x 27.9 cm
ISSN 1023-3830 (print)
ISSN 1420-908X (electronic)